Machine learning helps predict immunotherapy response in lymphoma patients

Researchers with City of Hope and Memorial Sloan Kettering (MSK) Cancer Center have created a tool that uses machine learning to assess a non-Hodgkin lymphoma (NHL) patient's likely response to chimeric antigen receptor (CAR) T cell therapy before starting the treatment, according to study results published in Nature Medicine.
👉 Full Story

The UNTHINKABLE Happens When Woman Visits Her Husband In Jail... #shorts
- Nintendo Switch 2: Everything announced including a new Mario Kart game, new Switch features and more - Nathan Ingraham
- Large study shows drinking alcohol is good for your cholesterol levels - Beth Mole
- Stand-Up Legend Mellows Out Without Losing Edge In Latest Hulu Special - Robert Scucci
- 6 Best Identity Theft Protection Services of April 2025
- YRKKH Written Update 11 August 2024: Abhira Refuses to Marry Arman as Ruhi’s Plan Unfolds! - Aaradhana Chaurasia
- A new security fund opens up to help protect the fediverse - Sarah Perez

Xiaomi 15: Is It Really That Good?
- Direct-to-consumer is redefining mobile game monetization - VB Staff
- AI effectively predicts dementia risk in American Indian/Alaska Native elders
- Trump’s national security adviser reportedly used his personal Gmail account to do government work - Zack Whittaker
- Donkey Kong: Bananza is a new platformer featuring Nintendo’s OG - Rachel Kaser
- Should You Add Turmeric to Your Coffee? 8 Reasons To Try It - Lindsey DeSoto, RD
- Does Exercise Help Acne or Make It Worse? What You Should Know - Carrie Madormo, RN, MPH